Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis

Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about OptimizeRx Corporation
OptimizeRx Corporation News
OptimizeRx Corporation Quantitative Score

About OptimizeRx Corporation
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.
OptimizeRx Corporation Earnings & Revenue
OptimizeRx Corporation Financials
Table Compare
Compare OPRX metrics with: | |||
---|---|---|---|
Earnings & Growth | OPRX | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | OPRX | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | OPRX | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | OPRX | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
OptimizeRx Corporation Income
OptimizeRx Corporation Balance Sheet
OptimizeRx Corporation Cash Flow
OptimizeRx Corporation Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
Metrics | Score |
---|---|
Discounted Cash Flows | Strong Sell |
Return on Equity | Strong Sell |
Return on Assets | Strong Sell |
Debt/Equity Ratio | Sell |
Price/Earnings Ratio | Strong Sell |
Price/Book Ratio | Strong Buy |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
OptimizeRx Corporation Valuation
Project future cash flows and get the intrinsic value per share.
Historical Market Cap
Shares Outstanding
OptimizeRx Corporation Executives
Name | Role |
---|---|
Mr. Edward Stelmakh C.M.A., M.B.A. | Chief Financial Officer & Chief Operating Officer |
Mr. Stephen L. Silvestro | President & Chief Executive Officer |
Ms. Marion K Odence-Ford | Chief Legal Officer & Chief Human Resources Officer |
Ms. Maira Alejandra | Media Relations Manager |
Ms. Theresa Greco | Chief Commercial Officer |
Name | Role | Gender | Date of Birth | Pay |
---|---|---|---|---|
Mr. Edward Stelmakh C.M.A., M.B.A. | Chief Financial Officer & Chief Operating Officer | Male | 1966 | 578.48K |
Mr. Stephen L. Silvestro | President & Chief Executive Officer | Male | 1978 | 544.96K |
Ms. Marion K Odence-Ford | Chief Legal Officer & Chief Human Resources Officer | Female | 1965 | 428.12K |
Ms. Maira Alejandra | Media Relations Manager | Female | -- | |
Ms. Theresa Greco | Chief Commercial Officer | Female | 1973 | -- |
OptimizeRx Corporation Insider Trades
Date | 14 Mar |
Name | Lang James Paul |
Role | Director |
Transaction | Acquired |
Type | P-Purchase |
Shares | 321408 |
Date | 1 Mar |
Name | Silvestro Stephen L |
Role | Chief Commercial Officer |
Transaction | Acquired |
Type | M-Exempt |
Shares | 1928 |
Date | 1 Mar |
Name | Silvestro Stephen L |
Role | Chief Commercial Officer |
Transaction | Disposed |
Type | F-InKind |
Shares | 572 |
Date | 1 Mar |
Name | Silvestro Stephen L |
Role | Chief Commercial Officer |
Transaction | Disposed |
Type | M-Exempt |
Shares | 1928 |
Date | 1 Mar |
Name | Odence-Ford Marion |
Role | Chief Legal Officer & CHRO |
Transaction | Acquired |
Type | M-Exempt |
Shares | 771 |
Date | Name | Role | Transaction | Type | Shares |
---|---|---|---|---|---|
14 Mar | Lang James Paul | Director | Acquired | P-Purchase | 321408 |
1 Mar | Silvestro Stephen L | Chief Commercial Officer | Acquired | M-Exempt | 1928 |
1 Mar | Silvestro Stephen L | Chief Commercial Officer | Disposed | F-InKind | 572 |
1 Mar | Silvestro Stephen L | Chief Commercial Officer | Disposed | M-Exempt | 1928 |
1 Mar | Odence-Ford Marion | Chief Legal Officer & CHRO | Acquired | M-Exempt | 771 |